Our analyses of TMA-based glioma patient cohort as well as TCGA glioma dataset consistently indicate that the expression of CD151 or α3β1 integrin is strongly correlated with tumor grade, IDH1 gene status, and patient survival. This evidence concerns the gene IDH1 and glioma.